ATE340788T1 - Herstellung von stereoisomeren von (3alpha, 3alpha/beta, 6alpha/beta)hexahydrofuro(2,3- böfuran-3-ol - Google Patents

Herstellung von stereoisomeren von (3alpha, 3alpha/beta, 6alpha/beta)hexahydrofuro(2,3- böfuran-3-ol

Info

Publication number
ATE340788T1
ATE340788T1 AT03762054T AT03762054T ATE340788T1 AT E340788 T1 ATE340788 T1 AT E340788T1 AT 03762054 T AT03762054 T AT 03762054T AT 03762054 T AT03762054 T AT 03762054T AT E340788 T1 ATE340788 T1 AT E340788T1
Authority
AT
Austria
Prior art keywords
3alpha
beta
preparation
hexahydrofuro
böfuran
Prior art date
Application number
AT03762054T
Other languages
English (en)
Inventor
Brian Daniel Doan
Daniel Edward Patterson
John C Roberts
Original Assignee
Smithkline Beecham Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Corp filed Critical Smithkline Beecham Corp
Application granted granted Critical
Publication of ATE340788T1 publication Critical patent/ATE340788T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/02—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
    • C07D493/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/26—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Seasonings (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Developing Agents For Electrophotography (AREA)
AT03762054T 2002-06-27 2003-06-25 Herstellung von stereoisomeren von (3alpha, 3alpha/beta, 6alpha/beta)hexahydrofuro(2,3- böfuran-3-ol ATE340788T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US39267702P 2002-06-27 2002-06-27

Publications (1)

Publication Number Publication Date
ATE340788T1 true ATE340788T1 (de) 2006-10-15

Family

ID=30000917

Family Applications (1)

Application Number Title Priority Date Filing Date
AT03762054T ATE340788T1 (de) 2002-06-27 2003-06-25 Herstellung von stereoisomeren von (3alpha, 3alpha/beta, 6alpha/beta)hexahydrofuro(2,3- böfuran-3-ol

Country Status (12)

Country Link
US (1) US20050261507A1 (de)
EP (1) EP1532127B1 (de)
JP (1) JP2005533821A (de)
AT (1) ATE340788T1 (de)
AU (1) AU2003247651A1 (de)
CY (1) CY1105856T1 (de)
DE (1) DE60308695T2 (de)
DK (1) DK1532127T3 (de)
ES (1) ES2268427T3 (de)
PT (1) PT1532127E (de)
SI (1) SI1532127T1 (de)
WO (1) WO2004002975A1 (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004060895A1 (ja) 2002-12-27 2004-07-22 Sumitomo Chemical Company, Limited ヘキサヒドロフロフラノール誘導体の製造方法、その中間体及びその製造方法
ES2359949T3 (es) * 2006-11-09 2011-05-30 Tibotec Pharmaceuticals Métodos para preparar hexhidrofuro(2,3-b)furan-3-ol.
AU2008317375B2 (en) * 2007-10-26 2013-02-28 Concert Pharmaceuticals, Inc. Deuterated darunavir
US8592487B2 (en) 2007-10-26 2013-11-26 Concert Pharmaceuticals, Inc. Deuterated darunavir
WO2010075887A1 (en) * 2008-12-30 2010-07-08 Oxyrane (Uk) Limited Methods and intermediates useful in the synthesis of hexahydrofuro[2,3-b]furan-3-ol
US20100305173A1 (en) * 2009-04-30 2010-12-02 Concert Pharmaceuticals, Inc. Hydroxyethylamino sulfonamide derivatives
PT2643326T (pt) 2010-11-23 2016-12-23 Mylan Laboratories Ltd Processo para a preparação de (3r,3as,6ar)-hexa-hidrofuro[2,3-b]furan-3-ol
EP2634180A1 (de) 2012-03-01 2013-09-04 Lonza Ltd. Enzymatisches Verfahren zur Herstellung von Butyrolactonen
ES2657227T3 (es) * 2012-08-09 2018-03-02 Sumitomo Chemical Company, Limited Método para producir un derivado de hexahidrofurofuranol
CN103864813B (zh) * 2012-12-18 2017-02-22 上海迪赛诺化学制药有限公司 一种合成六氢呋喃并[2,3‑b]呋喃‑3‑醇及其对映体的方法
WO2017041228A1 (zh) * 2015-09-08 2017-03-16 浙江九洲药业股份有限公司 六氢呋喃并呋喃醇衍生物的制备方法、其中间体及其制备方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002060905A2 (en) * 2000-10-24 2002-08-08 Glaxo Group Ltd Process for preparing intermediates of hiv protease inhibitors
ES2338538T3 (es) * 2001-09-10 2010-05-10 Tibotec Pharmaceuticals Metodo para la preparacion de hexahidrofuro(2,3-b)furan-3-ol.
WO2003024974A2 (en) * 2001-09-20 2003-03-27 Smithkline Beecham Corporation Process for preparing protease inhibitor intermediates

Also Published As

Publication number Publication date
JP2005533821A (ja) 2005-11-10
WO2004002975A1 (en) 2004-01-08
EP1532127B1 (de) 2006-09-27
DK1532127T3 (da) 2007-02-05
US20050261507A1 (en) 2005-11-24
EP1532127A1 (de) 2005-05-25
CY1105856T1 (el) 2011-02-02
AU2003247651A1 (en) 2004-01-19
DE60308695D1 (de) 2006-11-09
PT1532127E (pt) 2007-01-31
SI1532127T1 (sl) 2006-12-31
ES2268427T3 (es) 2007-03-16
DE60308695T2 (de) 2007-08-16

Similar Documents

Publication Publication Date Title
WO2003011115A3 (en) Peptide-based multimeric targeted contrast agents
WO2005005679A3 (en) Super-hydrophobic surfaces, methods of their construction and uses therefor
FR16C0028I2 (fr) Vecteurs viraux et utilisation de ces derniers dans des methodes therapeutiques
FI906212A7 (fi) HIV-proteaasin inhibiittoreita, jotka ovat käyttökelpoisia AIDSin hoidossa
MY142948A (en) Benzophenones as inhibitors of reverse transcriptase
ATE556059T1 (de) Pyrazolderivate zur behandlung von hiv
DE60105732D1 (de) Verfahren zur Herstellung von 3-l-Menthoxypropan-1,2-diol
DE60113496D1 (de) Verwendung von Glycyrrhizin zur Behandlung von Mastitis.
NO20013023L (no) Brystkopp, samt fremgangsmåte ved fremstilling av brystkopp, samt fremgangsmåte ved pumping av brystmelk ved hjelp av brystkoppen
BR0309581A (pt) Derivados de nucleosìdeo para tratamento de infecção por vìrus de hepatite c
AU2001235006A1 (en) Prophylactic and therapeutic monoclonal antibodies
PT1052905E (pt) Processo anti-germinativo de tuberculos e bolbos utilizando o eugenol e/ou o isoeugenol
WO2005102392A3 (en) Combinations for treating hiv infection
DK1373256T3 (da) CCR5-antagonister, der er nyttige til behandling af AIDS
DK1532127T3 (da) Fremstilling af stereoisomerer af (3alfa,3alfa/beta,6alfa/beta)hexahydrofuro(2,3-b)furan-3-ol
EP1256348A4 (de) Heilmittel gegen hepatitis
BR0210493A (pt) Composição, e, método para remover cerume humano
WO2004091436A3 (en) Methods and compositions for treating ocular disease
ATE369429T1 (de) Strukturproteine des virus, welches die pankreas- krankheit bei fischen verursacht, und ihre verwendungen
DK1765337T3 (da) Kombination af tenofovir, ritonavir og TMC114
ATE253578T1 (de) Oxazinochinolone zur behandlung von viralen infektionen
WO2002024867A3 (en) Novel compositions and methods for lymphoma and leukemia
ITRM20000266A0 (it) Procedimento migliorato per la preparazione di (e,z) 3-(2-amminoetossimmino)-androstano-6, 17-dione e di suoi analoghi.
DE60213874D1 (de) Verfahren zur herstellung von protease hemmenden zwischenprodukten
WO2004071462A3 (en) Methods and compositions for treatment of viral infections based on tsg101-vps28 interaction

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1532127

Country of ref document: EP

REN Ceased due to non-payment of the annual fee